$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000087786023000086 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$80.11M	$77.88M
YoY Change	4.99%	30.01%
Cost Of Revenue	$12.95M	$12.89M
YoY Change	11.67%	14.41%
Gross Profit	$67.15M	$64.98M
YoY Change	3.79%	33.63%
Gross Profit Margin	83.83%	83.44%
Selling, General & Admin	$4.500M	$4.738M
YoY Change	-11.01%	-15.59%
% of Gross Profit	6.7%	7.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.52M	$17.73M
YoY Change	-0.1%	-0.24%
% of Gross Profit	26.08%	27.28%
Operating Expenses	$52.01M	$49.74M
YoY Change	-8.64%	0.26%
Operating Profit	$15.14M	$15.24M
YoY Change	94.75%	-1651.93%
Interest Expense	$15.09M	$14.19M
YoY Change	32.19%	30.68%
% of Operating Profit	99.66%	93.14%
Other Income/Expense, Net	$200.0K
YoY Change
Pretax Income	$29.03M	$39.45M
YoY Change	-15.19%	83.77%
Income Tax
% Of Pretax Income
Net Earnings	$29.35M	$39.78M
YoY Change	-14.86%	83.54%
Net Earnings / Revenue	36.63%	51.08%
Basic Earnings Per Share	$0.68	$0.92
Diluted Earnings Per Share	$0.68	$0.92
COMMON SHARES
Basic Shares Outstanding	43.41M shares	43.39M shares
Diluted Shares Outstanding	43.39M shares	43.39M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.60M	$17.41M
YoY Change	-42.38%	-59.91%
Cash & Equivalents	$16.58M	$17.41M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$4.400M	$4.637M
Other Receivables	$83.50M	$82.30M
Total Short-Term Assets	$104.5M	$104.3M
YoY Change	-5.66%	-15.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.120B	$2.135B
YoY Change	-0.95%	-2.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.80M	$15.03M
YoY Change	-63.95%	-74.65%
Total Long-Term Assets	$2.395B	$2.394B
YoY Change	-0.14%	-2.84%
TOTAL ASSETS
Total Short-Term Assets	$104.5M	$104.3M
Total Long-Term Assets	$2.395B	$2.394B
Total Assets	$2.499B	$2.498B
YoY Change	-0.39%	-3.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.30M	$28.95M
YoY Change	27.41%	14.27%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$68.40M	$68.02M
YoY Change	10.24%	3.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.144B	$1.135B
YoY Change	2.64%	2.75%
Other Long-Term Liabilities	$5.400M	$5.284M
YoY Change	6.01%	23.4%
Total Long-Term Liabilities	$1.150B	$1.140B
YoY Change	2.65%	2.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$68.40M	$68.02M
Total Long-Term Liabilities	$1.150B	$1.140B
Total Liabilities	$1.218B	$1.208B
YoY Change	3.06%	2.88%
SHAREHOLDERS EQUITY
Retained Earnings	$2.435B	$2.405B
YoY Change
Common Stock	$1.603B	$1.602B
YoY Change	0.28%	0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.260B	$1.269B
YoY Change
Total Liabilities & Shareholders Equity	$2.499B	$2.498B
YoY Change	-0.39%	-3.43%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$29.35M	$39.78M
YoY Change	-14.86%	83.54%
Depreciation, Depletion And Amortization	$17.52M	$17.73M
YoY Change	-0.1%	-0.24%
Cash From Operating Activities	$49.70M	$50.50M
YoY Change	14.16%	-11.05%
INVESTING ACTIVITIES
Capital Expenditures	$2.600M	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$17.40M	$33.50M
YoY Change	-131.68%	-83.18%
Cash From Investing Activities	-$20.00M	$33.50M
YoY Change	-136.42%	-82.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.50M	-80.25M
YoY Change	-72.96%	-67.23%
NET CHANGE
Cash From Operating Activities	49.70M	50.50M
Cash From Investing Activities	-20.00M	33.50M
Cash From Financing Activities	-30.50M	-80.25M
Net Change In Cash	-800.0K	3.747M
YoY Change	-94.42%	-38.89%
FREE CASH FLOW
Cash From Operating Activities	$49.70M	$50.50M
Capital Expenditures	$2.600M	$0.00
Free Cash Flow	$47.10M	$50.50M
YoY Change	8.19%	-18.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Profit Loss ProfitLoss	39447000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-361000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74263000	usd
	us-gaap	Net Income Loss NetIncomeLoss	30073000	usd
CY2022Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	19000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	39760000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21673000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74244000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30073000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388753	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45708238	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388748	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45779433	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43388753	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45718538	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43390092	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45784771	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
	us-gaap	Profit Loss ProfitLoss	73630000	usd
	us-gaap	Profit Loss ProfitLoss	29712000	usd
	us-gaap	Depreciation Depreciation	35347000	usd
	us-gaap	Depreciation Depreciation	36044000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2082000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2156000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	234000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	739000	usd
	nhi	Amortization Of Lease Inducements AmortizationOfLeaseInducements	1075000	usd
	nhi	Amortization Of Lease Inducements AmortizationOfLeaseInducements	7419000	usd
	us-gaap	Straight Line Rent StraightLineRent	4972000	usd
	us-gaap	Straight Line Rent StraightLineRent	-13836000	usd
	nhi	Noncash Rental Income NoncashRentalIncome	2500000	usd
	nhi	Noncash Rental Income NoncashRentalIncome	0	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	784000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	2055000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-8838000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	12763000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13502000	usd
	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	0	usd
	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	1113000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	569000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-729000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-232000	usd
	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	10000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2874000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2632000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	776000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-196000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	81544000	usd
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	12174000	usd
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	9493000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	38081000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	4876000	usd
	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	48619000	usd
	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	108893000	usd
	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	4377000	usd
	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	2870000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2500000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	569000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5980000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	192223000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	231000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	95000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	77000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	95000000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	200000000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	365203000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	135192000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2747000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4598000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	638000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	522000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	78100000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	82531000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2922000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	11738000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	69977000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89766000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-281096000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2242000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6575000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39485000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19274000	usd
	us-gaap	Interest Paid Net InterestPaidNet	25971000	usd
	us-gaap	Interest Paid Net InterestPaidNet	20182000	usd
	nhi	Noncash Or Part Noncash Acquisition Real Estate Acquired In Exchange Of Mortgage Receivable NoncashOrPartNoncashAcquisitionRealEstateAcquiredInExchangeOfMortgageReceivable	14200000	usd
	nhi	Noncash Or Part Noncash Acquisition Real Estate Acquired In Exchange Of Mortgage Receivable NoncashOrPartNoncashAcquisitionRealEstateAcquiredInExchangeOfMortgageReceivable	9071000	usd
	us-gaap	Notes Issued1 NotesIssued1	699000	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
	nhi	Noncash Or Part Noncash Acquisition Change In Other Assets Related To Real Estate Sales NoncashOrPartNoncashAcquisitionChangeInOtherAssetsRelatedToRealEstateSales	0	usd
	nhi	Noncash Or Part Noncash Acquisition Change In Other Assets Related To Real Estate Sales NoncashOrPartNoncashAcquisitionChangeInOtherAssetsRelatedToRealEstateSales	102000	usd
	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	244000	usd
	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	0	usd
	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	67000	usd
	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	16000	usd
	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	275000	usd
	nhi	Operating Equipment Received In Transfer Of Operations OperatingEquipmentReceivedInTransferOfOperations	0	usd
	nhi	Operating Equipment Received In Transfer Of Operations OperatingEquipmentReceivedInTransferOfOperations	1287000	usd
	nhi	Capitalized Costs Transfer Of Operations CapitalizedCostsTransferOfOperations	0	usd
	nhi	Capitalized Costs Transfer Of Operations CapitalizedCostsTransferOfOperations	300000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1280081000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2000000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	273000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-305000	usd
CY2023Q1	nhi	Comprehensive Income Loss Net Of Tax Excluding Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxExcludingLossAttributableToNoncontrollingInterest	34488000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-275000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2105000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	39050000	usd
CY2023Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-1005000	usd
CY2023Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	290000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-270000	usd
CY2023Q2	nhi	Comprehensive Income Loss Net Of Tax Excluding Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxExcludingLossAttributableToNoncontrollingInterest	39717000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	243000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8246000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	7000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5083000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	41265000	usd
CY2022Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-28186000	usd
CY2022Q2	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	24000	usd
CY2022Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	243000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	227000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	21693000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	7000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	69977000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1428000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	40190000	usd
CY2022Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-87296000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1401501000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	5	property
CY2023Q2	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	14	mortgage
CY2023Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	238900000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15000000	usd
CY2023Q2	nhi	Number Of Joint Ventures NumberOfJointVentures	2	jointventure
CY2023Q2	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2022Q4	us-gaap	Cash Cash	19291000	usd
CY2021Q4	us-gaap	Cash Cash	37412000	usd
CY2023Q2	us-gaap	Cash Cash	17411000	usd
CY2022Q2	us-gaap	Cash Cash	43435000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	100000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	500000	usd
	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our leases generally provide for rent escalators throughout the term of the lease. Base rental income is recognized using the straight-line method over the term of the lease to the extent that lease payments are considered collectible and the lease provides for specific contractual escalators. Under certain leases, we receive additional contingent rent, which is calculated on the increase in revenues of the tenant over a base year or base quarter. We recognize contingent rent annually or </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly based on the actual revenues of the tenant once the target threshold has been achieved. Lease payments that depend on a factor directly related to future use of the property, such as an increase in annual revenues over a base year, are considered to be contingent rentals and are excluded from the schedule of minimum lease payments.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company reviews its operating lease receivables for collectability on a regular basis, taking into consideration changes in factors such as the tenant’s payment history, the financial condition of the tenant, business conditions in which the tenant operates and economic conditions in the area where the property is located. In the event that collectability with respect to any tenant is not probable, a direct write-off of the receivable is made as an adjustment to rental income and any future rental revenue is recognized only when the tenant makes a rental payment.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we had three tenants, including Bickford Senior Living (“Bickford”) on the cash basis of revenue recognition for their lease arrangements. Reference Note 3 for further discussion.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resident Fees and Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Resident fee revenue associated with our SHOP activities is recognized as the related performance obligations are satisfied and includes resident room charges, community fees and other resident charges. </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Residency agreements are generally short term (30 days to one year), and entitle the resident to certain room and care services for a monthly fee billed in advance. Revenue for certain related services is billed monthly in arrears. The Company has elected the lessor practical expedient within Accounting Standards Codification (“ASC”) 842, Leases, not to separate the lease and nonlease components within our resident agreements as the timing and pattern of transfer to the resident are the same. The Company has determined that the nonlease component is the predominant component within the contract and will recognize revenue under ASC 606, Revenue Recognition from Contracts with Customers.</span></div>
CY2023Q2	nhi	Number Of Tenants Cash Basis Revenue Recognition NumberOfTenantsCashBasisRevenueRecognition	3	tenant
	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from Mortgage and Other Notes Receivable </span>Interest income is recognized based on the interest rates and principal amounts outstanding on the notes receivable. We identify a mortgage note as non-performing if a required payment is not received within 30 days of the date it is due and a borrower’s current financial condition indicates a probability it cannot pay its current contractual amounts. A non-performing loan is returned to accrual status at such time as the note becomes contractually current and management believes all future principal and interest will be received according to the contractual terms of the note.
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In prior years, the Company presented "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cumulative dividends in excess of net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a single line item on the Condensed Consolidated Balance Sheets and the Condensed Consolidated Statements of Equity. Beginning January 1, 2023, the Company separated this line item into two components, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retained earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cumulative dividends,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and reclassified prior year information to conform to the current period presentation.</span></div>
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	14200000	usd
CY2023Q2	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	5	property
CY2022Q4	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	13	property
CY2023Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	13167000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	43302000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	500000	usd
CY2022Q2	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2600000	usd
CY2023Q2	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2600000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15000000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2430224000	usd
CY2023Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	238869000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23493000	usd
	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.15
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11992000	usd
	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.09
	us-gaap	Revenues Revenues	160264000	usd
	us-gaap	Revenues Revenues	131227000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	1863000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2225000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	26604000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	16585000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	112857000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	236575000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	240463000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	246996000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	201486000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	195894000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	658406000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1892677000	usd
CY2023Q2	us-gaap	Lease Income LeaseIncome	60952000	usd
CY2022Q2	us-gaap	Lease Income LeaseIncome	39982000	usd
	us-gaap	Lease Income LeaseIncome	126250000	usd
	us-gaap	Lease Income LeaseIncome	104541000	usd
CY2023Q2	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	14	property
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15000000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15017000	usd
CY2023Q2	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	223852000	usd
CY2023Q2	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2023Q2	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2023Q2	nhi	Estimated Credit Losses Current Conditions Adjustment Combined EstimatedCreditLossesCurrentConditionsAdjustmentCombined	0.44
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15338000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	-321000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15017000	usd
CY2023Q2	nhi	Annual Fixed Preferred Return AnnualFixedPreferredReturn	10200000	usd
CY2023Q2	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	4600000	usd
CY2023Q2	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	-5000000	usd
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	-5000000	usd
CY2023Q2	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-700000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	1300000	usd
CY2022Q2	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	900000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	1600000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
	nhi	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	extensionoption
CY2023Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	12900000	usd
CY2023Q2	us-gaap	Incentive To Lessee IncentiveToLessee	12115000	usd
CY2022Q4	us-gaap	Incentive To Lessee IncentiveToLessee	3190000	usd
CY2023Q2	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	196000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	42000000	usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10192000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8538000	usd
CY2023Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1134815000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1147511000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	50205000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	75425000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	325816000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	196000000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	100000000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	400000000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1147446000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2439000	usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10192000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2700000	usd
CY2023Q2	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	220000000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	100000	usd
	nhi	Debt Leverage Limit Coupon Change Trigger DebtLeverageLimitCouponChangeTrigger	0.50
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	13612000	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10262000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	27052000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	19819000	usd
CY2023Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	22000	usd
CY2022Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	9000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	41000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	10000	usd
CY2023Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	604000	usd
CY2022Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	609000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1210000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1251000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	14194000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	10862000	usd
	us-gaap	Interest Expense InterestExpense	28221000	usd
	us-gaap	Interest Expense InterestExpense	21060000	usd
	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	145400000	usd
CY2023Q2	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	23200000	usd
CY2023Q2	us-gaap	Development In Process DevelopmentInProcess	18000000	usd
CY2023Q2	nhi	Contingent Funding Commitment Amount Funded ContingentFundingCommitmentAmountFunded	1000000	usd
CY2023Q2	nhi	Contingent Funding Commitment ContingentFundingCommitment	13900000	usd
	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-380000	usd
CY2023Q2	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	303000	usd
CY2022Q2	nhi	Number Of Real Estate Properties Disposal Transactions NumberOfRealEstatePropertiesDisposalTransactions	3	property
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9825000	usd
	nhi	Contributions Attributable To Redeemable Noncontrolling Interest ContributionsAttributableToRedeemableNoncontrollingInterest	922000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-575000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10172000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	160000000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2468354	shares
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	151600000
CY2023Q1	nhi	Common Stock Value Maximum Issuance CommonStockValueMaximumIssuance	500000000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	500000	usd
CY2023Q2	nhi	Share Based Payment Arrangement Number Of Incentive Plans ShareBasedPaymentArrangementNumberOfIncentivePlans	2	plan
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.92
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.070
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.070
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.397
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.493
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0465
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0175
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1652505	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	78.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	718000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	53.62
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	53.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	23000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	62.33
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2263007	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.63
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1726987	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	74.18
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2216175	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.97
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5166	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	53.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	61168	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	66.44
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	88170	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	64.33
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M3D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2078827	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	71.40
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M3D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	nhi	Aggregate Intrinsic Value Per Share Options Exercised AggregateIntrinsicValuePerShareOptionsExercised	1.23
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
	nhi	Aggregate Intrinsic Value Per Share Options Exercised AggregateIntrinsicValuePerShareOptionsExercised	4.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21673000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30073000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388753	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45708238	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388748	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45779433	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388753	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45708238	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388748	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45779433	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	10300	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1344	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5338	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43388753	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45718538	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43390092	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45784771	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	903425	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	503862	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	776771	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	488187	shares
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.80
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.80
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	operatingsegment
CY2023Q2	us-gaap	Lease Income LeaseIncome	60952000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11793000	usd
CY2023Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5131000	usd
CY2023Q2	us-gaap	Revenues Revenues	77876000	usd
CY2023Q2	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	9682000	usd
CY2023Q2	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	3212000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	64982000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	17730000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	14194000	usd
CY2023Q2	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	174000	usd
CY2023Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	258000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4306000	usd
CY2023Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	186000	usd
CY2023Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	11366000	usd
CY2023Q2	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	39447000	usd
CY2023Q2	us-gaap	Assets Assets	2498495000	usd
CY2022Q2	us-gaap	Lease Income LeaseIncome	39982000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11992000	usd
CY2022Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7925000	usd
CY2022Q2	us-gaap	Revenues Revenues	59899000	usd
CY2022Q2	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	9113000	usd
CY2022Q2	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2157000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	48629000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	17772000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	10862000	usd
CY2022Q2	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	339000	usd
CY2022Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	225000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5049000	usd
CY2022Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	4094000	usd
CY2022Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	10521000	usd
CY2022Q2	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-729000	usd
CY2022Q2	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	1113000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	273000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	21466000	usd
CY2022Q2	us-gaap	Assets Assets	2587291000	usd
	us-gaap	Lease Income LeaseIncome	126250000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23493000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10521000	usd
	us-gaap	Revenues Revenues	160264000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	19481000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	5830000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	134953000	usd
	us-gaap	Depreciation Depreciation	35347000	usd
	us-gaap	Interest Expense InterestExpense	28221000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	297000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	441000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9959000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-232000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	12763000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
	us-gaap	Profit Loss ProfitLoss	73630000	usd
	us-gaap	Lease Income LeaseIncome	104541000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11992000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	14694000	usd
	us-gaap	Revenues Revenues	131227000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	9113000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	5195000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	116919000	usd
	us-gaap	Depreciation Depreciation	36044000	usd
	us-gaap	Interest Expense InterestExpense	21060000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	2166000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	469000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13150000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	28622000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13502000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-729000	usd
	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	1113000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-151000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	569000	usd
	us-gaap	Profit Loss ProfitLoss	29712000	usd
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000877860-23-000086-index-headers.html	Edgar Link	pending
0000877860-23-000086-index.html	Edgar Link	pending
0000877860-23-000086.txt	Edgar Link	pending
0000877860-23-000086-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhi-20230630.htm	Edgar Link	pending
nhi-20230630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nhi-20230630_cal.xml	Edgar Link	unprocessable
nhi-20230630_lab.xml	Edgar Link	unprocessable
nhi-20230630_def.xml	Edgar Link	unprocessable
nhi-20230630_htm.xml	Edgar Link	completed
nhi-6302023x10qex311.htm	Edgar Link	pending
nhi-6302023x10qex312.htm	Edgar Link	pending
nhi-6302023x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nhi-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2023 Q3 Form 10-Q Financial Statement

#000087786023000086 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2023 Q3 Form 10-Q Financial Statement

#000087786023000086 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi